quinidine has been researched along with angiotensin ii in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (50.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kritcher, EM; Luchi, RJ | 1 |
| Alps, BJ; Borrows, ET; Johnson, ES; Staniforth, MW; Wilson, AB | 1 |
| Abboud, FM; Heistad, DD; Mark, AL; Nelson, LD; Schmid, PG | 1 |
| Caldwell, RW; Elam, JT; Mecca, TE; Nash, CB | 2 |
| Lotshaw, DP | 2 |
| Mercure, C; Reudelhuber, TL; Touyz, RM | 1 |
| Touyz, RM; Yao, G | 2 |
10 other study(ies) available for quinidine and angiotensin ii
| Article | Year |
|---|---|
Drug effects on cardiac myosin adenosine triphosphatase activity.
Topics: Adenosine Triphosphatases; Adenosine Triphosphate; Angiotensin II; Animals; Binding Sites; Calcium; Chloralose; Cyclopropanes; Digoxin; Dogs; Epinephrine; Ethers; Heart; Heart Failure; In Vitro Techniques; Isoproterenol; Lidocaine; Magnesium; Muscle Contraction; Muscle Proteins; Myocardium; Nitrous Oxide; Norepinephrine; Ouabain; Pentobarbital; Pharmacology; Procainamide; Protein Binding; Quinidine; Secobarbital | 1967 |
A comparison of the cardiovascular actions of indoramin, propranolol, lignocaine, and quinidine.
Topics: Amides; Angiotensin II; Animals; Blood Pressure; Cats; Depression, Chemical; Epinephrine; Female; Heart; Heart Rate; Hemodynamics; Indoles; Isoproterenol; Lidocaine; Male; Muscle Contraction; Norepinephrine; Piperidines; Propranolol; Quinidine; Vascular Resistance | 1972 |
Inhibition of adrenergic vasoconstriction by quinidine.
Topics: Adult; Analysis of Variance; Angiotensin II; Animals; Blood Pressure; Blood Vessels; Denervation; Dogs; Dose-Response Relationship, Drug; Electric Stimulation; Forearm; Heart Rate; Hindlimb; Humans; Male; Muscles; Nitroglycerin; Norepinephrine; Perfusion; Quinidine; Regional Blood Flow; Serotonin; Sympathetic Nervous System; Time Factors | 1974 |
alpha-Adrenergic blocking properties of quinine HCl.
Topics: Adrenergic alpha-Antagonists; Angiotensin II; Animals; Aorta; Blood Pressure; Calcium; Cardiovascular System; Dogs; Dose-Response Relationship, Drug; Epinephrine; Female; Heart Rate; In Vitro Techniques; Isoproterenol; Male; Muscle Contraction; Myocardial Contraction; Norepinephrine; Quinidine; Quinine; Rabbits; Vascular Diseases; Vasoconstrictor Agents | 1980 |
Vascular alpha-adrenergic blocking properties of quinidine.
Topics: Adrenergic alpha-Antagonists; Angiotensin II; Animals; Aorta, Thoracic; Azepines; Blood Pressure; Dogs; Female; Hexamethonium Compounds; Histamine; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Norepinephrine; Phenylephrine; Quinidine; Rabbits; Rats; Rats, Inbred Strains; Vasoconstriction | 1983 |
Characterization of angiotensin II-regulated K+ conductance in rat adrenal glomerulosa cells.
Topics: Aldosterone; Angiotensin II; Animals; Biphenyl Compounds; Cells, Cultured; Cesium; Female; Imidazoles; Ion Transport; Losartan; Membrane Potentials; Nystatin; Patch-Clamp Techniques; Potassium; Potassium Channels; Quinidine; Rats; Rats, Sprague-Dawley; Signal Transduction; Tetrazoles; Zona Glomerulosa | 1997 |
Effects of K+ channel blockers on K+ channels, membrane potential, and aldosterone secretion in rat adrenal zona glomerulosa cells.
Topics: Aldosterone; Angiotensin II; Animals; Apamin; Cells, Cultured; Cesium; Charybdotoxin; Electrophysiology; Female; Membrane Potentials; Patch-Clamp Techniques; Potassium; Potassium Channel Blockers; Potassium Channels; Quinidine; Rats; Rats, Sprague-Dawley; Zona Glomerulosa | 1997 |
Angiotensin II type I receptor modulates intracellular free Mg2+ in renally derived cells via Na+-dependent Ca2+-independent mechanisms.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenergic alpha-Antagonists; Adrenergic Uptake Inhibitors; Amiloride; Angiotensin II; Animals; Antihypertensive Agents; Benzofurans; Biphenyl Compounds; Calcium; Calcium Channel Agonists; Cell Line; Cells, Cultured; Chelating Agents; Cytosol; Dogs; Dose-Response Relationship, Drug; Egtazic Acid; Ethers, Cyclic; Fluorescent Dyes; Fura-2; Imidazoles; Imipramine; Irbesartan; Kidney; Kinetics; Magnesium; Microscopy, Fluorescence; Peptides; Pyridines; Quinidine; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Sodium; Tetrazoles; Time Factors | 2001 |
Inhibitors of Na+/Mg2+ exchange activity attenuate the development of hypertension in angiotensin II-induced hypertensive rats.
Topics: Angiotensin II; Animals; Antiporters; Biological Transport; Blood Platelets; Blood Pressure; Body Weight; Cations; Cells, Cultured; Hypertension; Imipramine; Intracellular Membranes; Magnesium; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Quinidine; Rats; Rats, Sprague-Dawley; Sodium; Vasoconstrictor Agents | 2003 |
Up-regulation of vascular and renal mitogen-activated protein kinases in hypertensive rats is normalized by inhibitors of the Na+/Mg2+ exchanger.
Topics: Angiotensin II; Animals; Antiporters; Blood Pressure; Body Weight; Hypertension; Imipramine; Kidney Cortex; Male; Mesenteric Arteries; Mitogen-Activated Protein Kinases; Phosphorylation; Quinidine; Rats; Rats, Sprague-Dawley; Up-Regulation | 2003 |